8-K - Arcturus Therapeutics Holdings Inc. (0001768224) (Filer)
Published . Updated .
Key takeaways
- 8-K - Arcturus Therapeutics Holdings filed an 8-K with the SEC on Nov 16 (a notice of a material company event).
- Exposed: ARCT
- Market reaction: price tracking starts with the next trading session.
Market Call
Think this story will push the stock up or down over the next three trading days? Make a free call and see what other readers think. Points are play money with no cash value.
Get these market calls by email
The week's biggest market-moving stories, Congress trades and Trump posts, with the tickers they touch. Free, one email a week.
Free. We only use your email to send the digest, never sell or share it, and every email has a one-click unsubscribe link. See our privacy policy.
8-K - Arcturus Therapeutics Holdings filed an 8-K with the SEC on Nov 16 (a notice of a material company event).
Directly affected
- ARCT Arcturus Therapeutics Holdings-41.6% 30d
Named in this report.
Indirectly affected
- XLV Health Care Select Sector SPDR
Health Care Select Sector SPDR holds the health sector that Arcturus Therapeutics Holdings belongs to, so it often moves with news about it.
- LLY Eli Lilly and+25.1% 30d
Eli Lilly and is a peer of Arcturus Therapeutics Holdings in pharmaceutical preparations; rivals often move on the same news.
- JNJ Johnson & Johnson+12.1% 30d
Johnson & Johnson is a peer of Arcturus Therapeutics Holdings in pharmaceutical preparations; rivals often move on the same news.
- ABBV AbbVie+12.0% 30d
AbbVie is a peer of Arcturus Therapeutics Holdings in pharmaceutical preparations; rivals often move on the same news.
- MRK Merck+3.5% 30d
Merck is a peer of Arcturus Therapeutics Holdings in pharmaceutical preparations; rivals often move on the same news.
- ABT Abbott Laboratories+10.0% 30d
Abbott Laboratories is a peer of Arcturus Therapeutics Holdings in pharmaceutical preparations; rivals often move on the same news.
Price reaction, T-5 to T+3
| Ticker | T-5 | T-3 | T-1 | T0 | T+1 | T+2 | T+3 |
|---|---|---|---|---|---|---|---|
| ARCT | +13.91% | +11.81% | base | after close | after close | after close | after close |
| XLV | -0.28% | +0.04% | base | after close | after close | after close | after close |
| LLY | -2.25% | -0.49% | base | after close | after close | after close | after close |
| JNJ | -1.35% | -1.97% | base | after close | after close | after close | after close |
| ABBV | -0.57% | -0.04% | base | after close | after close | after close | after close |
| MRK | +0.65% | -0.38% | base | after close | after close | after close | after close |
| ABT | +1.85% | +0.80% | base | after close | after close | after close | after close |
Closing-price change versus T-1, the last close before the story. T0 to T+3 fill in after each market close. Prices: Alpaca IEX.
Filed: 2026-11-16 AccNo: 0001193805-26-001485 Size: 211 KB Item 1.01: Entry into a Material Definitive Agreement Item 3.02: Unregistered Sales of Equity Securities Item 7.01: Regulation FD Disclosure Item 9.01: Financial Statements and Exh…
Source: sec-edgar
How far Arcturus Therapeutics Holdings (ARCT) has moved since 16 Nov 2026
| Company | When | Move | Status |
|---|---|---|---|
| ABBV | three days earlier | -0.04% | final price |
| ABBV | five days earlier | -0.57% | final price |
| ABT | three days earlier | +0.80% | final price |
| ABT | five days earlier | +1.85% | final price |
| Arcturus Therapeutics Holdings (ARCT) | three days earlier | +11.81% | final price |
| Arcturus Therapeutics Holdings (ARCT) | five days earlier | +13.91% | final price |
| JNJ | three days earlier | -1.97% | final price |
| JNJ | five days earlier | -1.35% | final price |
| LLY | three days earlier | -0.49% | final price |
| LLY | five days earlier | -2.25% | final price |
| MRK | three days earlier | -0.38% | final price |
| MRK | five days earlier | +0.65% | final price |
| XLV | three days earlier | +0.04% | final price |
| XLV | five days earlier | -0.28% | final price |
Congressional trades in the stocks in this story
- Rep. David J. Taylor sold Eli Lilly (LLY), worth $1,001 - $15,000 on 3 Nov 2026. That is 13 days before publication. Filed 12 Nov 2026. View the filing.
- Rep. Gilbert Cisneros bought Eli Lilly (LLY), worth $1,001 - $15,000 on 20 Oct 2026. That is 27 days before publication. Filed 10 Nov 2026. View the filing.
- Rep. Rohit Khanna bought Eli Lilly (LLY) (held by a spouse), worth $1,001 - $15,000 on 4 Sep 2026. That is 73 days before publication. Filed 7 Oct 2026. View the filing.
- Rep. Rohit Khanna sold Johnson & Johnson (JNJ) (held by a spouse), worth $15,001 - $50,000 on 7 Oct 2026. That is 40 days before publication. Filed 5 Nov 2026. View the filing.
- Rep. Thomas H. Kean Jr sold Johnson & Johnson (JNJ), worth $1,001 - $15,000 on 30 Sep 2026. That is 47 days before publication. Filed 30 Oct 2026. View the filing.
- Rep. Rohit Khanna bought Johnson & Johnson (JNJ) (held by a spouse), worth $1,001 - $15,000 on 25 Sep 2026. That is 52 days before publication. Filed 7 Oct 2026. View the filing.
- Rep. Rohit Khanna bought AbbVie (ABBV) (held by a spouse), worth $1,001 - $15,000 on 7 Oct 2026. That is 40 days before publication. Filed 5 Nov 2026. View the filing.
- Rep. Pete Sessions sold AbbVie (ABBV), worth $15,001 - $50,000 on 14 Sep 2026. That is 63 days before publication. Filed 18 Sep 2026. View the filing.
- Rep. Rohit Khanna sold AbbVie (ABBV) (held by a spouse), worth $1,001 - $15,000 on 4 Sep 2026. That is 73 days before publication. Filed 7 Oct 2026. View the filing.
- Rep. Maria Elvira Salazar sold Merck (MRK), worth $1,001 - $15,000 on 24 Sep 2026. That is 53 days before publication. Filed 7 Oct 2026. View the filing.
- Rep. Maria Elvira Salazar bought Merck (MRK), worth $15,001 - $50,000 on 19 Aug 2026. That is 89 days before publication. Filed 9 Sep 2026. View the filing.
- Rep. Rohit Khanna bought Abbott Laboratories (ABT) (held by a spouse), worth $1,001 - $15,000 on 7 Oct 2026. That is 40 days before publication. Filed 5 Nov 2026. View the filing.
Public disclosure filings, not a recommendation. The filing link is the source document. News use of these reports still sits under 5 U.S.C. § 13107(c).
Who gains and who loses around Arcturus Therapeutics Holdings (ARCT)
Companies carried with this story
- ARCT Arcturus Therapeutics Holdings
Arcturus Therapeutics Holdings (ARCT) is linked, with no stored direction, high confidence in the 16 Nov 2026 story “8-K - Arcturus Therapeutics Holdings Inc. (0001768224) (Filer).” Reason on file: SEC 8-K filing -> direct issuer disclosure -> ARCT
Arcturus Therapeutics Holdings (ARCT)
On 16 Nov 2026, “8-K - Arcturus Therapeutics Holdings Inc. (0001768224) (Filer)” is the story that connects Arcturus Therapeutics Holdings (ARCT) to this story.
What ties Arcturus Therapeutics Holdings (ARCT) to the headline is this: SEC 8-K filing -> direct issuer disclosure -> ARCT
The price range for Arcturus Therapeutics Holdings (ARCT), and the dates in the story
ARCT traded between 8.42 and 15.15 across 16 sessions. The latest close on file is 8.44.
What the saved facts support for Arcturus Therapeutics Holdings (ARCT)
14 out of 100
“8-K - Arcturus Therapeutics Holdings Inc. (0001768224) (Filer)” scores 14 out of 100. The score uses 1 sources, and 1 linked companies.